Heather Savelle

Heather Savelle is the current Vice President of Investor Relations at TScan Therapeutics. Prior to their current position, Heather was a Managing Director at Argot Partners, LLC from September 2016 to September 2021. Heather has also held the position of Senior Vice President at MacDougall Biomedical Communications from December 2013 to August 2016 and Sr. Director, Investor and Public Relations/Corporate Communications at Targacept, Inc. from March 2010 to December 2013.

Heather has extensive experience in proactively managing all elements of corporate communications programs, developing and implementing strategic corporate communications plans, creating strategic messaging materials, and conducting ongoing research and analysis of competitors and peers. Heather is also skilled in interfacing with the media and pitching news to appropriate public channels. In their previous positions, Heather has served as a strategic resource to CEOs, CFOs, and senior management teams on messaging and key message training for corporate spokespeople. Additionally, Heather has managed all external investor relations and corporate communications consultants, worked with research and development staff to develop and track scientific publication strategy, and maintained a presence at relevant medical and scientific conferences.

Heather’s experience in corporate communications and investor relations make their an invaluable asset to the TScan team. Her ability to develop and implement effective communications strategies will help ensure that TScan’s message is properly communicated to both internal and external audiences.

Heather Savelle has a B.A. in Sociology from UC Santa Barbara and they attended Amador Valley High School.

Heather Savelle reports to David Southwell, CEO. They work with Ray Lockard - VP, Technical Operations & Quality, Brian M. Silver - CFO, and Gavin MacBeath - Chief Scientific Officer.